文献库搜索 | GeneLibs

Cornish(N),Ward(R),Warkentin(MT),Thirlwell... J Thromb Haemost 2026-05-00

...TP53 (HR, 1.55; 95% CI, 1.38-1.73). TMB of ≥20 mutations/Mb and 2 DNA mismatch repair signatures (SBS6 and SBS26) associ...

Senapati(J),Croden(J),Garcia-Manero(G),Tak... Hemasphere 2026-02-00

...TP53 mutation. Composite complete response rates were higher with LIT + VEN compared to LIT (58% vs. 40%, P = 0.003) but...

Zhang(J),Zhao(Z),Xiang(T),Teng(D),Wan(H),Z... Front Aging Neurosci None

...TP53, AKT1, STAT3, MYC, RELA, EP300, CREBBP, JUN, HSP90AA1, and MAPK3 as central nodes. Enrichment analyses implicated F...

Zhang(MY),Sun(RQ),Min(Q),Zhu(YQ),Qin(SK),G... World J Gastroenterol 2026-02-14

...TP53. Clinical data has verified that the upregulation of key components of this pathway (TP53, MDM2, MDM4, and cyclin-d...

Almahari(SA),Al-Ani(M),Zaitoun(AM),Gordon(... Front Oncol None

...TP53 c.811G>A p. (Glu271Lys) (VAF 0.90). Targeted panel sequencing showed no other actionable mutations. MSI readout was...

S(AR),Raj(FJ),Sundararajan(VV),Thangaraj(P... RSC Adv 2026-02-11

...TP53. Molecular docking and dynamics simulations demonstrated stable binding of KLM-derived flavonoids with BCRP, MRP1, ...

Xu(X),Zhou(S),Li(C),Liu(X),Cao(X),Wang(X),... ACS Omega 2026-02-10

...TP53, and AKT1. GO and KEGG analyses reveal that the mechanisms primarily involve the regulation of apoptotic signaling ...

Stolnicu(S),Hoang(L),Rakislova(N),Horn(LC)... Virchows Arch 2026-04-00

...TP53 and portending worse survival. Recent developments have expanded the spectrum of squamous intraepithelial lesions (...

Singh(A),Sahani(P),Singh(S),Ojha(A),Gupta(... Arch Microbiol 2026-02-16

...TP53 codon 72 (Arg/Pro), DNA repair and metabolic genes (XRCC1, MTHFR), and detoxification gene null genotypes (GSTM1, G...

Paksoy(B),Erkal(O),Kocaaga(A) Clin Transl Oncol 2026-08-00

...TP53 (1.4%). VUS and benign/VUS variants were detected in 4.6% (30/647) and 3.1% (20/647) of individuals, respectively. ...